Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacripep in Neurotrophic Keratitis
NCT07568730Phase 2Recruiting
- Sponsor
- TearSolutions, Inc.
- Start
- Feb 2026
- Primary completion
- Feb 2027
- Modality
- Recombinant Proteins and Enzymes, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Lacripep in neurotrophic keratitis (NK), sponsored by TearSolutions, Inc.. Started Feb 2026; status: recruiting.
02
Drugs
Lacripep
03
Conditions
neurotrophic keratitis (NK)
Beyond the preview
Go deeper on NCT07568730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07568730.